骨康胶囊引起严重肝损害2例及经验教训*

doi:10.3969/j.issn.1672-5069.2017.02.037

Abstract

Zhou Xueshi，Yin Cuilan，Lu Zhonghua，et al.. Drug-induced liver injury：a report of two cases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 250-251.

[1] 徐静，汪茂荣. 土三七导致肝小静脉闭塞综合征研究进展. 实用肝脏病杂志，2013，16（1）:94-96.
[2] 郑文凯，汪茂荣. 土三七导致酒精性肝硬化患者肝小静脉闭塞综合征的临床特点分析. 中国肝脏病杂志（电子版），2015，7（1）:51-54.
[3] 周宏华，徐晓玲，关心，等. 土三七致肝小静脉闭塞病13例报道及文献复习. 实用肝脏病杂志，2015，18（3）:304-305.
[4] 房龙，樊艳华. 土三七致肝小静脉闭塞病的分析. 临床荟萃，2010，25（3）:213-217.
[5] 房龙，樊艳华，王晓娣，等. 土三七致肝小静脉闭塞病的临床分析与文献复习. 中日友好医院学报，2010，24（1）:3-7.
[6] 方军伟，张智勤，潘锦辉，等. 土三七致肝小静脉闭塞病的血小板及凝血功能临床表现分析. 中国现代应用药学，2015，32（7）:874-875.
[7] 姚玲娣. 土三七致肝小静脉闭塞病的诊断及治疗. 现代中西医结合杂志，2014，23（30）:3371-3372.
[8] 黄焕军，刘瑶，林菊生，等. 土三七致肝小静脉闭塞病诊断及治疗体会. 临床消化病杂志，2008，20（1）:26-28.
[9] 凌美，武谦虎. 土三七致肝小静脉闭塞症81例文献分析. 药物不良反应杂志，2013，15（5）:254-257.
[10] 徐立宇，钦丹萍. 中药土三七致肝小静脉闭塞病的文献分析. 中国中西医结合消化杂志，2015，10（2）:143-144.
[11] 吉力，徐植灵. 补骨脂化学成分的综述. 中国中药杂志，1995，20（2）:120-122.
[12] 吴疆，魏巍，袁永兵. 补骨脂的化学成分和药理作用研究进展. 药物评价研究，2011，34（3）:217-219.
[13] Mar W，Je K H，Seo E K. Cytotoxic constituents of Psoralea corylifolia. Arch Pharm Res，2001，24（3）:211-213.
[14] Whelan LC，Ryan MF. Ethanolic extracts of euphorbia and other ethnobotanical species as inhibitors of human tumour cell growth. Phytomedicine，2003，10（1）:53-58.
[15] 谭沛，赵超，周昆，等. 补骨脂灌胃30天对大鼠肝毒性的实验研究. 新疆中医药，2010，28（2）:11-13.
[16] 毕亚男，李震，卢国彦，等. 补骨脂水提物对小鼠的肝毒性及胆汁酸转运的影响. 药物评价研究，2015，10（3）:267-270.
[17] Palmeira C M，Rolo A P. Mitochondrially-mediated toxicity of bile acids. Toxicology，2004，203（1-3）:1-15.
[18] 于乐成，茅益民，陈成伟. 药物性肝损伤诊治指南. 中国病毒病杂志，2015，31（5）:321-341.
[19] 王学勤，李丰林，张维国. 中药药物性肝损害研究进展. 亚太传统医药，2015，11（5）:35-36.
[20] Martinez MA，Vuppalanchi R，Fontana RJ， et al. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol，2015，13（2）:369-376.
[21] Andrade RJ，Lucena MI，Kaplowitz N，et al. Outcome of acute idiosyncratic drug-induced liver injury:Long-term follow-up in a hepatotoxicity registry. Hepatology，2006，44（6）:1581-1588.
[22] 何维新，范平，陈玺卿. 骨康胶囊致药物性肝炎6例分析. 临床军医杂志，2009，37（3）:520-521.

Drug-induced liver injury：a report of two cases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[2]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[3]	Zhang Xuan, Tang Xiaoyun, Tang Chunyin, et al. Effect of Chinese herbal medicine on intestinal microflora in mice with D-galactosamine/LPS-induced acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 478-481.
[4]	Li Gaoming, Lyu Bihua. Effect of combination of entecavir and herbal medicine on negative emotion in patients with chronic hepatitis B and depression [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 498-501.
[5]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[6]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[7]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[8]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[9]	Hongjie, Zhou Dongfang.. Efficacy of entecavir and Chinese herbal medicine combination therapy in patients with hepatitis B-induced liver cirrhosis An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 903-906.
[10]	Liang Yong Li Miao Zhou Shilan, etal.. Clinical observation of herbal medicine in treatment of patients with icteric chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 975-976.
[11]	Gao Xiang, Shang Shuangyan. Protective effect of Fufangbiejia, a herbal medicine, on diethylnitrosamine-induced primary liver cancer in rats and its impact on PCNA and α-SMA expression [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 553-556.
[12]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[13]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[14]	Liu Jinguo, Wang Baokui. Efficacy of Fufangbiejia Ruanganpian and ursodeoxycholic acid combination in the treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 340-343.
[15]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.